Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study

Table 1

Patient characteristics.

	Hydromorphone	Sufentanil	Oxycodone
Number of patients	30	34	21
Male/female	18/12	18/16	13/8
Age (years)	59.8 ± 9.8	61.8 ± 9.4	59.9 ± 10.6
Cancer location
Gastrointestinal	22	23	14
Bronchopulmonary	4	6	1
Urogenital	1	2	1
Others	3	3	5
Metastases present	28	33	19
Main location of pain
Head/neck/upper extremity	2	2	1
Thorax	4	5	3
Abdomen-pelvic	20	24	14
Hip/lower extremity	3	1	2
Multiple sites of pain	1	2	1